CONTAINER FOR HARMLESS NEEDLES.

Abstract

This document describes single and double packaging for loading needles and blank needles. Such packaging may include hard or hollow packaging. Such packaging may include an early activation prevention element arranged on an inner side wall of a compartment of the packaging to fit into a cavity of a blank needle device catheter to prevent accidental activation of the blank needle device before use.

Description

This description refers in general to packaging for medical devices and, more specifically, to double packaging for passive inert needles that require rotation of a catheter or housing for passive activation. BACKGROUND Clean or sterile items, especially those used in medical applications, are packaged to maintain their sterility. The packaging of these items is designed to provide a barrier to prevent microorganisms from entering and contaminating the contents. In most cases, the packaging is opened immediately before use, as with a blister pack containing a syringe or needle, to minimize the time the item is exposed to non-sterile conditions. Traditionally, physicians who load and inject syringes may use a one-needle or two-needle technique. In the one-needle technique, the physician loads the syringe with a container (for example, a vial) containing a liquid and uses the same needle for the injection. In the two-needle technique, the physician loads the syringe with a first needle but replaces it with a new needle before the injection. Both the single-needle and two-needle techniques offer certain advantages and disadvantages. For example, the single-needle technique is convenient because the physician does not have to change needles between loading and injection, but the needle can become contaminated between loading and injection. The two-needle technique allows the use of specialized needles that are optimized for loading and injection, but it is more cumbersome for the physician. Consequently, there is a need for alternative packaging systems to provide users with sterile needles. There is also a need for packaging to prevent the unintentional activation of passively activated, non-sterile needles that require rotation of a catheter or housing for passive activation. COMPENDIUM One aspect of the present description relates to a packaging system comprising a needle-free device having a catheter and a retractable cuff. The catheter includes a recess at its distal end, and the retractable cuff can be advanced into the catheter. The packaging system further includes a hard container having a closed distal end, an open proximal end, and a compartment extending between the closed distal end and the open proximal end. A premature activation prevention element for the compartment fits within the recess of the needle-free device. A seal is provided. MA / t / ZUZZ / U 7 OUOÓ removable against the open proximal end, wherein the compartment and removable seal define a sealed region, where the safe needle device is disposed within the sealed region. In one or more modalities, the safe needle device is either a passive safe needle or an active safe needle. In one or more embodiments, the early activation prevention element comprises at least one rail, where the at least one rail has a projection that protrudes and extends from an inner side wall of the compartment, where the projection protrudes and extends towards the center of the compartment. In one or more embodiments, the protruding projection has a width that is slightly less than the width of the cavity of the non-toxic needle device. The protruding projection prevents rotation of the non-toxic needle device when it is positioned within the compartment. A second aspect of the present description relates to a packaging system comprising a non-invasive needle device having a catheter and a retractable cuff. The catheter includes a recess disposed at a distal end, and the retractable cuff is movable into the catheter. The packaging system further includes a hard container comprising a first compartment, and a second hard container having a closed distal end, an open proximal end, and a second compartment extending between the closed distal end and the open proximal end. An early activation prevention element disposed on an inner side wall of the compartment is removably fitted into the catheter recess of the non-invasive needle device. The early activation prevention element is at least one rail having a protruding projection that fits into the recess of the non-invasive needle device.A removable seal is positioned against the open proximal end, where the compartment and the removable seal define a sealed region, within which the non-toxic needle device is disposed. A second removable seal is placed against the second compartment. This second removable seal defines a second sealed region within which the non-toxic needle is disposed. The first hard package is attached to the second hard package. In one or more embodiments, at least one rail arranged on an interior side wall of the compartment extends from a closed distal end of the compartment at least partially along the length of the compartment. In one or more modalities, at least one rail arranged on an inner side wall of the compartment extends from a closed distal end of the compartment to the open proximal end. In one or more modalities, at least one rail has a width that is less than the width of the hole of the harmless needle device. MA / t / ZUZZ / U / OUOÓ In one or more of the following embodiments, the first hard container is connected to the second hard container by means of a snap fit, an adhesive bond, a solvent bond, a ring connector, a snap closure, a C-clip snap closure, thermal embedding, or ultrasonic welding. In one or more embodiments, the first hard container has a perforated joint to the second hard container. In one or more embodiments, the first removable part comprises a first tab and the second removable part comprises a second tab. In one or more forms, the first removable seal includes graphics, symbols, diagrams, words, or instructions to indicate that the first removable seal should be opened first. In one or more forms, the second removable seal includes graphics, symbols, diagrams, words, or instructions to indicate that the first removable seal should be opened second. In one or more forms, the first hard container has a first color and the second hard container has a second color. A third aspect of the present description relates to a packaging system comprising a needle, a needleless device, and a hollow container having a first cavity and a second cavity. The second cavity has an early activation prevention element to fit within the recess of the needleless device. The first and second cavities are sealed against a backing, where the first cavity and the backing define a first sealed region, and where the second cavity and the backing define a second sealed region. A distal end of the needle is disposed within the first sealed region, and a distal end of a second needle is disposed within the second sealed region. In one or more forms, the needle is a blunt-tipped loading needle. In one or more modalities, the harmless needle device is either a passive harmless needle or an active harmless needle. In one or more embodiments, the recess has a width that is slightly greater than the width of the protruding trigger element of the compartment, where the protruding trigger element prevents rotation of the harmless needle device when the protruding trigger element is engaged in the recess. In one or more modalities, a cap is placed around the distal end of the needle. In one or more forms, the alveolar container includes a peel-off tab. BRIEF DESCRIPTION OF THE FIGURES Figure 1 illustrates a single package for a harmless needle device; Figures 2A and 2B illustrate a harmless needle device from Figure 1; Figure 3A illustrates one compartment of the single container of Figure 1; MA / t / ZUZZ / U / OUOÓ Figure 3B illustrates a cross-sectional view of the single-container compartment of Figure 1; Figure 3C illustrates a detailed cutaway view of the single container compartment of Figure 1; Figure 4A illustrates the harmless needle device that is disposed of inside the single-pack compartment of Figure 1; Figure 4B illustrates a detailed view of the harmless needle device arranged within the single-container compartment of Figure 1; Figure 4CB illustrates a detailed side and perspective view of the harmless needle device disposed within the single-container compartment of Figure 1; Figure 4D illustrates an exploded view of the harmless needle device and the single compartment of Figure 1; Figure 5 illustrates a double container with two tabs; Figure 6 illustrates a hard container having two removable parts with two tabs; Figure 7 illustrates a honeycomb container that contains a blunt-tipped loading needle and a harmless needle. DETAILED DESCRIPTION Before describing several illustrative modalities of this description, it should be understood that the modalities of this description are not limited to the construction details or process stages set forth herein. The modalities of this description may include other modalities and may be implemented or carried out in various ways. With regard to the terms used in this description, the following definitions are provided. As used herein, the use of "a / an" and "the" includes both singular and plural. The term "needle" includes needles suitable for drawing up and / or injecting liquids into or out of a syringe. In this description, a convention is followed whereby the portion of a needle closest to the practitioner handling the needle is called the "proximal" portion, and the portion of the needle toward the patient (for injection) or the vial containing the liquid (for drawing up), farther from the practitioner, is called the "distal" portion. In various forms, the needles described herein may be blunt-tipped drawing-up needles, non-lethal needles, and / or conventional needles. As used herein, a "drawing needle" refers to a needle that is suitable for drawing up a syringe but may not be suitable for injection. For example, a drawing needle might be a blunt-tipped needle that is not suitable for penetrating the skin of a MA / t / ZUZZ / U / OUOÓ patient. As used herein, a "safety needle" refers to a needle suitable for injection that includes one or more features to prevent needlestick injuries. In one or more forms, a safe needle includes a sheath that covers the distal end of the needle. As used herein, an "active safe needle" refers to a safe needle with a user-controlled activation mechanism that covers the distal end of the needle after injection into a patient. As used herein, a "passive safe needle" refers to a safe needle with a passive activation mechanism that automatically covers the distal end of the needle after injection into a patient. Any suitable needle device comprising a safety feature may be used in conjunction with the packaging described herein. Example safety needle devices include, but are not limited to, those described in jointly owned U.S. patent applications 62 / 433,294, 62 / 433,350, 62 / 479,507, and 62 / 533,786, the descriptions of which are incorporated herein in their entirety by reference. The types of safety features vary in structure and mechanics, but generally, safety needle devices have a loaded state and an injection state. The reference to "syringe" includes syringes that are indicated for use with needles, nozzles, tubing, or for use in delivery systems. As used herein, the term "syringe" refers to a simple pump-like device consisting of a plunger that fits snugly into a cylinder or tube. The plunger can be pulled or pushed into the cylinder, allowing the syringe to draw in and expel a liquid or gas through an opening at the open end of the cylinder. The open end of the syringe may be fitted with a needle, nozzle, or tubing to help direct the flow of fluid into and out of the cylinder. The syringe may be sterile or non-sterile, depending on the technician's needs. As used herein, the terms "container" or "packaging" include any material used to wrap or protect a good or product, such as a syringe or needle. The container may be hard or flexible. The term "container" includes, but is not limited to, medical containers, pharmaceutical containers, and child-resistant containers. Medical and pharmaceutical containers may include bubble wrap or hard containers. As used herein, the terms "bucket packaging" or "blister pack" encompass various types of preformed packaging used for consumer goods, food, pharmaceuticals, medical devices, etc. The main component of a bubble package is a cavity or pocket made of a moldable mesh, usually a thermoformed plastic. The moldable mesh may be rigid or flexible. The cavity or pocket is large enough to hold the product placed inside the bubble package. MA / t / ZUZZ / U / OUOÓ The application, a honeycomb container can have a thermoformable backing and a lid seal made of aluminum foil, paper, Tyvek®, plastic, or other medical-grade materials. Honeycomb containers can also be hinged, which may include a rigid backing, such as cardboard. Honeycomb containers can provide a protective barrier against microorganisms and other contaminants, and can offer a degree of tamper resistance. Among the many options offered by honeycomb containers, they must protect the product inside while still allowing for automated processing. Cleft pods are commonly used as unit-dose packaging for pharmaceutical tablets, capsules, or pills. The pharmaceutical product and its cleft pod act together as an integral unit. The cleft pod protects the pharmaceutical product from external influences that would otherwise render it unusable, while also allowing the pharmaceutical manufacturer to package it using form-fill-seal equipment. The form-fill-seal process involves creating the cleft pod from rolls of flat sheets or films, loading it with the pharmaceutical product, such as a medication tablet, and closing (sealing) it. This type of cleft pod is sometimes called a "push-in" pod because the consumer can push the product (e.g., the medication tablet) through the backing.With pharmaceutical blister packs, manufacturers must be concerned about the moisture vapor transmission rate of the blister pack because many pharmaceuticals degrade and lose their efficacy through hydrolysis. Furthermore, the blister pack must provide an oxygen barrier to prevent degradation of the pharmaceutical product by oxidation. In one or more configurations, the blister pack is a push-type package. Bubble packs containing medical devices, such as syringes, differ from pharmaceutical bubble packs in that medical bubble packs are not push-type packs. Instead, the thermoformed base mesh is made of a thicker plastic and cannot be pushed in, thus forming a solid backing. The lid film provides a peel-open feature that can be opened with both hands, such as the knuckle-peel technique. The lid film of a medical bubble pack is typically porous to allow for sterilization. Often, medical bubble packs are made of Tyvek® or a similar medical-grade material that is breathable and gas-permeable but not permeable to microorganisms. The lid film may also be made of medical-grade paper or a completely waterproof or non-breathable film.In cases where a non-breathable film is used, sterilization is performed by radiation (e.g., electron beams). In one or more modalities, the. MA / t / ZUZZ / U / OUOÓ alveolated container is a medical alveolated container. Cellular containers can be created by thermoforming or cold forming. In thermoforming, a sheet or film of plastic is unwound from a reel and guided through a preheating station on the cell container line. The temperature of the preheating plates softens the plastic, making it flexible. The heated plastic then reaches a forming station where high pressure forms the cell cavity in a negative mold. The mold is then cooled so that the plastic hardens again and retains its shape when removed from the mold. In cold forming, a sheet of aluminum laminate is simply pressed against a mold using a die. The aluminum stretches and retains the molded shape. The use of aluminum provides a complete barrier to water and oxygen. However, cold-formed hollow containers take longer to produce compared to thermoformed ones. Cold-formed hollow containers are also not transparent, which can lead to non-compliance with pharmaceutical treatments by consumers. The thermoformable backing of a medical bubble container is typically made of a flexible, thermoformable plastic film. The film often has several layers. The main component is usually a layer of approximately 15–30% nylon, while the remaining layers may comprise substances including, but not limited to, polyethylene. The sealing layer may include, among other things, ethylene vinyl acetate (EVA). The lid film of a medical bubble container can be made of plastic, aluminum, or medical-grade papers that are permeable to gases for sterilization but impermeable to microorganisms. Most commonly, Tyvek® is used as the lid material for medical bubble containers. The term "cell pack" can also include packaging known as skin pack, where a cardboard or other backing material and the product are covered with a thin, clear plastic film. The backing typically has a heat-sealable liner. The plastic film is softened with heat and placed over the product on the backing. Sometimes a vacuum is used to ensure a tight fit. Immediately after forming the cell pack, it is transported to a vacuum-sealing station where a vacuum is applied and the cell pack is sealed, providing a tight fit. The plastic film adheres to the heat-sealable liner of the cardboard or other backing. In one or more of these configurations, the cell pack is a thermoformed, vacuum-sealed cell pack. Cellular containers can be sealed in a variety of ways, including, but not limited to, heat sealing and cold sealing. The lid materials can be treated with a... MA / t / ZUZZ / U / OUOÓ heat-sealing coating; the lid is then sealed to the cover using heat, which activates the coating. Cellular containers can also be sealed using a cold-sealing process, which uses a combination of a pressure-sensitive, folding cell card and a transparent cell; the cell is sandwiched between two pieces of cardboard that are pressed together without heat. Additionally, cellular containers can be sealed by correctly orienting multiple layers of film to create a seal. As used herein, the term “hard container” or similar includes containers having a compartment with one or more openings that can be covered to create a seal. In one or more embodiments, the hard container includes one or more components made of a hard material such as a rigid polymer. Examples of rigid polymer materials include, but are not limited to, polyester, polycarbonate, polyethylene, polystyrene, or polypropylene, or combinations or copolymers thereof. In one or more embodiments, a hard container may be thermoformed or molded, for example, by injection molding. The techniques described above for hollow containers may be applied to the rigid parts of hard containers and / or to removable portions of hard containers. As used herein, the term "microorganism" refers to a microbe or organism that is unicellular or lives in a colony of cellular organisms. Microorganisms are very diverse; they include, but are not limited to, bacteria, fungi, archaea, and protozoa. Tyvek® is a synthetic material consisting of evaporated, high-density polyethylene fibers (i.e., a continuous filament olefin fiber). The material is lightweight and strong, and tear-resistant, but can be cut with scissors or a knife. Water vapor and other gases can pass through Tyvek® because the material is highly breathable, but at the same time, it is impermeable to liquid water and microorganisms. As used herein, the term "sterilization" refers to a means of eliminating or killing microorganisms present on a surface, contained in a fluid, or in a compound such as a biological culture medium, to achieve asepsis or a sterile microbial environment. Sterilization can be achieved by applying heat, chemicals, irradiation / radiation, high pressure, filtration, or combinations thereof. Chemical sterilization includes sterilization with gases such as ethylene oxide, hydrogen peroxide gas, and ozone; liquids such as chlorine bleach, iodine, glutaraldehyde and formaldehyde, ortho-phthalaldehyde (OPA), hydrogen peroxide, peracetic acid, sodium hydroxide, silver, and cobalt. Radiation sterilization involves the use of radiation such as electron beams (E-beams), X-rays, gamma rays, or subatomic particles. As used herein, the expression "knuckle peel technique" refers to the process by which a technician, such as a doctor or nurse, opens a package to ML / t / ZUZZ / U / OUOÓ release the product inside. With a twisting motion of the knuckles, the outer packaging material is separated with both hands and the product inside is released. Several variations of the description herein provide dual-packaging systems containing two needles. In one or more variations, this dual packaging can help improve workflow and efficiency for users of the two-needle technique by eliminating the need to remember to obtain two needles instead of one. In one or more variations, this dual packaging can also be helpful for clinicians who traditionally use a one-needle loading and injecting technique, as these clinicians may not be accustomed to obtaining a separately packaged component. In one or more variations, this dual packaging can also help enhance compliance in clinical settings where managers want clinicians to use a two-needle technique, but the clinicians prefer the more convenient one-needle technique.In one or more modalities, double packaging can be beneficial because it helps prevent a user from accidentally or intentionally injecting a patient with a loaded device. For passive safety, injection with a loaded device could prevent the safety mechanism from activating. In one or more modalities, providing two needles allows a user to perform the injection with a second, blunt-tipped needle that has been recapped or has not been at risk of contamination by contact. In one or more modalities, the two needles include a loading needle (e.g., a blunt-tipped loading needle) and an injection needle (e.g., a non-toxic needle). In other modalities, one or both needles are conventional needles. One or more of the modalities of the present description refer to a single-compartment or two-compartment packaging system that has a hard container. Figure 1 illustrates an example embodiment of a single-compartment packaging system 100. As illustrated, compartment 120 can accommodate a non-toxic needle device 130. A removable seal 140 is disposed against the open proximal end 122. As shown in Figure 1, compartment 120 can be molded in one piece, for example by injection molding. Figures 2A and 2B illustrate a needle-safe device 130 comprising a retractable sleeve 134 having a protruding activation element 132 that can advance within a catheter 136, wherein the retractable sleeve and the catheter 136 are disposed within a housing 138. The retractable sleeve at least partially covers a needle 135 in an initial state. The catheter 136 includes a recess 139 disposed at a distal end of the catheter. As described in further detail below, the recess 139 of the catheter 136 is interlocked with an early activation prevention element 125, as shown in Figures 3A-3C of the compartment 120, to prevent unintentional activation of the retractable sleeve 134 during transport. MA / t / ZUZZ / U / OUOÓ storage or packaging in general. For illustrative purposes, in Figure 2B, the housing 138 has been removed for clarity. In one or more embodiments, the protruding activation element 132 is an integral part of the retractable sleeve 134. In one or more embodiments, the harmless needle device 130 is a passive harmless needle. In one or more embodiments, the harmless needle device 130 is an active harmless needle. As shown in Figure 3A-3C, the single-compartment packaging system 100 may include a hard container having a closed distal end 121, an open proximal end 122, and a compartment 120 extending between the closed distal end 121 and the open proximal end 122. A removable seal 140 is disposed against the open proximal end 122. The compartment 120 and the removable seal 140 define a sealed region in which the non-toxic needle device 130 is disposed. The removable seal 140 may be a tab. As shown in Figure 3B–3C, compartment 120 includes an early activation prevention element 125 that fits within the recess (not shown) of the inert needle device 130. In the preferred embodiment, the early activation prevention element 125 includes at least one rail 126 disposed on an inner side wall 129 of compartment 120 that extends from the closed distal end 121 at least partially along the length of the compartment. In one or more embodiments, the at least one rail 126 extends to the open proximal end. The at least one rail 126 has a width that is less than the width of the recess 139 of the inert needle device 130.In one or more embodiments, the early activation prevention element 125 comprises two parallel rails, where the two parallel rails are spaced apart such that they are configured to fit within the width of the opening 139 of the harmless needle device 130. In one or more embodiments, the early activation prevention element 125 comprises a single unit rail. As shown in Figure 3C, at least one rail 126 includes a protruding projection 128. The protruding projection 128 extends toward the center of compartment 120. The protruding projection 128 is configured to fit into recess 139. As shown in Figures 4A–4D, the harmless needle device 130 is arranged within compartment 120. For clarity, a spring of the harmless needle device 130 has been hidden from view to better illustrate the protrusion 128 of the early activation element 125, which fits into the recess 139 of the harmless needle device 130. When the harmless needle device 130 is arranged within compartment 120, the protruding flange 128 of the early activation prevention element 125 of compartment 120 fits into the recess 139 of the housing 138 of the harmless needle device 130. The early activation element 125 of compartment 120 prevents premature or inadvertent activation of the harmless needle device 130 by preventing rotation of the device. MA / t / ZUZZ / U / OUOÓ innocuous needle 130. Because at least one rail 126 of the early activation element 125 has a width that is less than the width of the cavity 139 of the catheter 136, the protruding projection 128 sits within the cavity 139. In one or more modalities, the width of at least one rail 126 is slightly less than the width of the cavity 139, allowing only minimal rotation, but not free rotation of the innocuous needle device 130 within compartment 10. Figure 5 illustrates an example embodiment of a double packaging system 200. The packaging system has a first compartment 220 that can accommodate a first needle and a second compartment 250 that can accommodate a non-toxic needle device 230. As shown in Figure 3, the first compartment 220 and the second compartment 250 can be molded in one piece, for example by injection molding. The first compartment 220 has an opening that is covered by a first removable seal 225. The first removable seal 225 is sealed against the first compartment 220, so the first compartment 220 and the first removable seal 225 define a first sealed region. The first removable seal 225 may include a tab for a user to grasp in order to remove the first removable seal 225 and access the first compartment 220. In one or more embodiments, the first removable seal 225 may include graphics, symbols, diagrams, words, or other instructions to indicate that it should be opened first. For example, the first removable seal 225 may include the number "1". The first removable part may also include graphics, symbols, diagrams, words, or other instructions to indicate the intended use of the needle stored in the first compartment 220. In one or more embodiments, the first removable seal 225 may include graphics, symbols, diagrams, words, or other instructions to indicate that it should be opened first. The second compartment 250 has an opening that is covered by a second removable seal 255. The second compartment 250 includes an early activation prevention element 235 disposed within the compartment that can be engaged in a recess 239 disposed in a distal end of a catheter 236 of the non-invasive needle device 230. In one or more embodiments, the early activation prevention element 235 is in the form of at least one rail 226 disposed in an inner side wall of the compartment 250. In one or more embodiments, the early activation prevention element 225 is interposed with the recess 239 of the protruding activation element 232. The at least one rail 226 includes a protruding projection 228. The protruding projection 228 is directed toward the center of the compartment 250. The protruding projection 228 is configured to engage within the recess 239. The second removable seal 255 is sealed against the second compartment 250, so the second compartment 250 and the second removable seal 255 define a second sealed region. The second removable seal 255 may include a second tab 260 so that a MA / t / ZUZZ / U / OUOÓ user grab it to remove the second removable seal 255 and access the second compartment 250. The second removable seal 255 may include graphics, symbols, diagrams, words, or other instructions to indicate that it should be opened second. For example, the second removable seal 255 may include the number "2". The second removable part may also include graphics, symbols, diagrams, words, or other instructions to indicate the intended use of the needle stored in the second compartment 250. For example, if the needle stored in the second compartment 250 is to be used to inject a patient, the second removable seal 255 may include a graphic showing a person with a syringe. In addition, if the needle stored in the second compartment 250 is a single-use needle device that locks after use, the second removable seal 255 may also include a locking symbol. Figure 6 illustrates an example embodiment of a double packaging system 300. The packaging system has a first compartment 320 that can accommodate a first needle and a second compartment 350 that can accommodate a non-toxic needle device 330. As shown in Figure 4, the first compartment 320 and the second compartment 350 can be molded separately and joined by a connection 375. In one or more embodiments, the first compartment 320 can be joined to the second compartment 350 by means of a snap fit, an adhesive bond, a solvent bond, a ring connect, a snap closure, a C-clip snap closure, thermal embedding, or ultrasonic welding. In one or more embodiments, the first compartment 320 can be joined to the second compartment 350 by means of a punched or temporary connection. In one or more embodiments, the first 320 compartment and the second 350 compartment are made of different materials or are different colors. For example, in one or more embodiments, the first 320 compartment may be colored to indicate a specific use (e.g., red to indicate a blunt-tipped loading needle), and the second 350 compartment may be transparent, semi-transparent, or a different color to indicate a specific use. In other embodiments, both the first 320 and second 350 compartments are transparent or semi-transparent, or are the same color. The first compartment 320 has an opening that is covered by a removable part 325. The first removable seal 325 is sealed against the first compartment 320, so the first compartment 320 and the first removable seal 325 define a first sealed region. The first removable seal 325 may include a first tab for a user to grasp in order to remove the first removable seal 325 and access the first compartment 320. The second compartment 350 has an opening that is covered by a second seal MA / t / ZUZZ / U / OUOÓ removable 355. The second removable seal 355 is sealed against the second compartment 350, so the second compartment 350 and the second removable seal 355 define a second sealed region. The second removable seal 355 may include a second tab 360 for a user to grasp in order to remove the second removable seal 355 and access the second compartment 350. The second compartment 350 includes an early activation prevention element 335 within the compartment, which fits into a recess 339 of a catheter 336 of the non-invasive needle device 330. In one or more modalities, the early activation prevention element 335 is sandwiched between the recess 339 of the catheter 336 of the non-invasive needle device 330. The second removable seal 355 is sealed against the second compartment 350, so the second compartment 350 and the second removable seal 355 define a second sealed region. The second removable seal 355 may include a second tab 360 for a user to grasp in order to remove the second removable seal 355 and access the second compartment 350. The first removable seal 325 and the second removable seal 355 may include any of the features described above for the first removable seal 325 and the second removable seal 355, such as graphics, symbols, diagrams, words, or other instructions to indicate the order in which the compartments are opened or the intended use of the needles stored in the compartments. One or more embodiments of the present description relate to a double-packaging system having a hollow container. Figure 7 shows an example embodiment of a double-packaging system 400. A first cavity 420 houses at least a portion of a needle 405, and a second cavity 450 houses at least a portion of a non-stick needle device 435. In one or more embodiments, the first cavity 420 houses a syringe and a pre-installed blunt-tipped loading needle. The non-stick needle device 435 has a protruding trigger element 436. In one or more embodiments, the needle 405 and the non-stick needle device 435 can be packaged side-by-side in a double hollow-packaging system 400. In one or more embodiments, the second cavity 450 has a recess 460 to accommodate the protruding activation element of the non-toxic needle device. The distal portion 410 of the needle 405 may be covered with a harder material than the proximal portion 415 of the first needle. The distal portion 410 of the needle 405 may be covered by a cap 490. Similarly, the distal portion 440 of the non-toxic needle device 435 may be covered with a hard material. The distal portion 445 of the non-toxic needle device 435 may be covered with a cap 490. A backing 485 may provide a seal against the first cavity 420 and the second cavity 450. The blister pack may also include a peel-off tab 495 for opening the pack MA / / OUOÓ alveolated. In one or more configurations, the peel-off direction is on the right side of the package to reduce the possibility of contamination. In another configuration, the peel-off direction is on the left side of the package. References throughout this descriptive report to "a modality," "certain modalities," "one or more modalities," or "a modality" mean that a specific feature, structure, material, or characteristic described with respect to that modality is included in at least one modality of the description. Therefore, the occurrence of phrases such as "in one or more modalities," "in certain modalities," or "in a modality" in various passages throughout this report does not necessarily refer to the same modality of the description. Furthermore, particular features, structures, materials, or characteristics may be combined in any appropriate way within one or more modalities. Although the description herein has been given with reference to particular embodiments, it should be understood that these embodiments are merely illustrative of the principles and applications of this description. It will be evident to those skilled in the art that various modifications and variations of this description may be made without departing from its spirit or scope. Therefore, this description is intended to include modifications and variations that fall within the scope of the appended claims and their equivalents.

Claims

1. A packaging system comprising: a non-toxic needle device having a catheter and a retractable cuff, wherein the catheter includes a recess disposed at a distal end of the catheter; and a hard container having a closed distal end, an open proximal end, and a compartment extending between the closed distal end and the open proximal end; an early activation prevention element of the compartment fitting within the recess of the non-toxic needle device; and a removable seal disposed against the open proximal end, whereby the compartment and the removable seal define a sealed region, wherein the non-toxic needle device is disposed within the sealed region.

2. The packaging system of claim 1, wherein the harmless needle device is a passive harmless needle or an active harmless needle.

3. The packaging system of claim 1, wherein the early activation prevention element comprises at least one rail, wherein the at least one rail has a projection that protrudes and extends from an inner side wall of the compartment, wherein the protruding projection extends towards the center of the compartment.

4. The packaging system of claim 3, wherein the protruding projection has a width that is slightly less than the width of the cavity of the harmless needle device, wherein the protruding projection prevents rotation of the harmless needle device when the harmless needle device is disposed of within the compartment.

5. A packaging system comprising: a non-invasive needle device having a housing, a catheter, and a retractable cuff, wherein the retractable cuff is advanceable within the catheter, wherein the catheter has a recess disposed at a distal end of the catheter; a first hard container comprising a first compartment; a second hard container having a closed distal end, an open proximal end, and a second compartment extending between the closed distal end and the open proximal end; an early activation prevention element disposed on an inner side wall of the compartment to fit removably within the catheter recess of the non-invasive needle device, wherein the early activation prevention element is at least one rail, wherein the at least one rail has a protruding projection that fits within the recess of the non-invasive needle device;a first removable seal sealed against the first compartment, where the first MA / t / ZUZZ / U / OUOÓ compartment and the first removable seal define a first sealed region, where the needle is disposed within the first sealed region; a second removable seal sealed against the second compartment, where the second removable seal defines a second sealed region, where the innocuous needle device is disposed within the second sealed region where the first hard container joins the second hard container.

6. The packaging system of claim 5, wherein the at least one rail disposed in an inner side wall of the compartment extends from a closed distal end of the compartment at least partially along the length of the compartment.

7. The packaging system of claim 6, wherein the at least one rail disposed in an inner side wall of the compartment extends from a closed distal end of the compartment to the open proximal end.

8. The packaging system of claim 5, wherein the at least one rail has a width that is less than the width of the hole of the harmless needle device.

9. The packaging system of claim 5, wherein the first hard container is connected to the second hard container by means of a snap fit, an adhesive bond, a solvent bond, a ring connector, a snap closure, a C-clip snap closure, thermal embedding, or ultrasonic welding.

10. The packaging system of claim 5, wherein the first hard container has a perforated joint to the second hard container.

11. The packaging system of claim 5, wherein the first removable part comprises a first tab and the second removable part comprises a second tab.

12. The packaging system of claim 11, wherein the first removable seal includes graphics, symbols, diagrams, words or instructions to indicate that the first removable seal should be opened first.

13. The packaging system of claim 11, wherein the second removable seal includes graphics, symbols, diagrams, words or instructions to indicate that the first removable seal should be opened second.

14. The packaging system of claim 11, wherein the first hard container has a first color and the second hard container has a second color.

15. A packaging system comprising: a needle having a distal end and a proximal end; a sterile needle device having a cavity disposed at a distal end of the catheter; and a honeycomb container having a first cavity and a second cavity having an early activation prevention element to fit within the cavity of the sterile needle device, wherein the first and second cavities are sealed against a backing, the first cavity and the backing define a first sealed region, the second cavity and the backing define a second sealed region, the distal end of the needle is disposed within the first sealed region, and the distal end of a second needle is disposed within the second sealed region.

16. The packaging system of claim 15, wherein the needle is a blunt-tipped loading needle.

17. The packaging system of claim 15, wherein the harmless needle device is a passive harmless needle or an active harmless needle.

18. The packaging system of claim 15, wherein the recess has a width that is slightly greater than the width of the protruding activation element of the compartment, wherein the protruding activation element prevents rotation of the harmless needle device when the protruding activation element is engaged in the recess.

19. The packaging system of claim 15, further comprising a cap arranged around the distal end of the needle.

20. The packaging system of claim 15, wherein the honeycomb container includes a peel-off tab.

Images